Response
Surface Modeling of Propofol-Remifentanil Interaction on Ventilatory Control
and Bispectral Index
DJF
Nieuwenhuijs, E Olofsen, DS Ward, FHM Engbers, J Vuyk, RR Romberg, LJ Teppema,
EY Sarton, and A Dahan.
Department
of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
Introduction: Intravenous
anesthetics and opioids are frequently combined for monitored anesthesia care.
Respiratory depression is a serious side effect of both anesthetics and
opioids. Therefore we quantified the nature of the interaction (additive versus
synergistic) of the combination of remifentanil and propofol on ventilatory
control and bispectral index of the EEG (BIS).
Methods: The effect of steady state concentrations of
remifentanil and propofol, given separately and in combination, was assessed in
22 healthy male volunteers. After measurement of resting ventilation, the
ventilatory response to steady-state hypercapnia was assessed. The ranges of
target blood concentrations of remifentanil and propofol were 0 - 3.5 ng/ml for
remifentanil and 0-2 mg/ml for propofol. In each subject
at least one control, remifentanil alone, propofol alone and propofol-remifentanil
combined measurement were obtained (i.e. at least 4 measurements per
subject). The nature of interaction was assessed by response surface modeling1
using the pharmacodynamic model:
E(Cr,Cp) = E0 . [1- {(Cr . (lr)1/g + Cp . (lp)1/g )g } . I(Q) ]
where E0 is the baseline value, Cr and Cp are the concentrations of remifentanil and
propofol respectively and l denotes the degree of depression
of the respective drug at a concentration halfway its range in the design (in
our case 1 ng/ml and 1 mg/ml). We opted to use the factors l,
instead of using C50`s, because these cannot be well
estimated as they typically lie well above the applied concentration ranges. g is a
nonlinearity parameter and I(Q) is a smooth function (spline) of Q which equals
Cr /( Cr + Cp).
I(Q) is characterized by parameters Imax and Qmax denoting the maximum value of the interaction
and the value of Q at which I(Qmax) = Imax respectively. The population model parameters
for resting ventilation (Vi), resting end-tidal PCO2 (PETCO2),
ventilation at a fixed end-tidal PCO2 of 55 mmHg (V55) and BIS were estimated by
NONMEM using a population approach. The Akaike criterion was used to determine
significance of nonlinearity (g¹1) and
synergism (Imax>1). Values are population
estimate ± SE.
Results: A total of 94 responses were obtained at different drug combinations.
The ranges of the measured arterial remifentanil and propofol concentrations
were 0-2 ng/ml and 0-2.6 mg/ml, respectively. Table 1 gives
the result of the NONMEM analysis. Synergistic interactions were found for all
parameters, except for the BIS, where we found an inert interaction.
Conclusions: Our results are clinically important as they show that at the relatively
low doses at which remifentanil and propofol exhibit only additive interactions
with respect to suppression of somatic and autonomic responses to noxious
stimulation and stress,2 the
interaction on ventilatilatory depression is synergistic. Note however, that
our subjects were without pain and stress. Extrapolation of our data to
patients in pain should therefore be done with care. Our data are relevant to
patients on remifentanil and propofol given a regional block to undergo their
surgery.
REFERENCES:
1. Dahan et al. Anesthesiology 2000 94:
982-91. 2. Mertens. PhD thesis 2002,
Leiden University, Leiden.
|
|
Vi L/min |
V55 L/min |
PETCO2 mmHg |
BIS |
|
Baseline value |
9.4 ± 0.3 |
31.4 ± 1.5 |
41.2 ± 0.1 |
96.7 ± 0.3 |
|
l remifentanil† |
27.7 ± 0.1 |
57.7 ± 0.1 |
15.4 ± 0.1 |
- |
|
l propofol† |
12.6 ± 0.1 |
44.3 ± 0.1 |
4.2 ± 0.1 |
17.8 ± 0.1 |
|
Imax (Q)* |
1.9 ± 0.2 |
1.2 ± 0.1 |
1.3 ± 0.2 |
- |
|
g** |
0.5 ± 0.1 |
0.4 ± 0.1 |
0.7 ± 0.1 |
1 |
|
C50 remifentanil# |
3.3 |
0.7 |
5.6 |
- |
|
C50 propofol$ |
16.0 |
1.4 |
36.9 |
2.6 |
Table 1.
Estimated population model parameters.
C50`s are extrapolated. Qmax was never significantly different from 0.5.
†percentage depression at 1ng/ml
(remifentanil) and 1mg/ml (propofol),
*>1
denotes synergy, **1 denotes nonlinearity, #(ng/ml), $(mg/ml).